6-K 1 oct15_6k.txt FORM 6-K FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2004 Commission File Number: 001-10378 AVENTIS (Translation of registrant's name into English) 67917 STRASBOURG, CEDEX 9 FRANCE (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F [X] Form 40-F [ ] Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):_______ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):_______ Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes [ ] No [X] If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): Not applicable On October 15, 2004, Rhone-Poulenc Overseas Limited, a wholly-owned subsidiary of Aventis, issued the press release attached hereto as Exhibit 99.1. Exhibit 99.1 is incorporated herein by reference. EXHIBIT LIST EXHIBIT NO. DESCRIPTION ------------ -------------------------------------------------------- Exhibit 99.1 Press Release dated October 15, 2004, issued by Rhone- Poulenc Overseas Limited relating to the redemption of its 8-1/8% Cumulative Preference Shares, Series A. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AVENTIS (Registrant) Date: October 15, 2004 By: /s/ JEAN-CLAUDE LEROY ------------------------------ Name: Jean-Claude Leroy Title: Member of the Management Board and Chief Financial Officer EXHIBIT INDEX EXHIBIT NO. DESCRIPTION ------------ -------------------------------------------------------- Exhibit 99.1 Press Release dated October 15, 2004, issued by Rhone-Poulenc Overseas Limited relating to the redemption of its 8-1/8% Cumulative Preference Shares, Series A.

FORM 6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934

For the month of October 2004

Commission File Number: 001-10378

AVENTIS

(Translation of registrant’s name into English)

67917 Strasbourg, cedex 9

France

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ý Form 40-F o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes o No ý

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): Not applicable

On October 4, 2004, Aventis issued the press release attached hereto as Exhibit 99.1.

Exhibit 99.1 is incorporated herein by reference.

Exhibit List

Exhibit No.		Description
Exhibit 99.1		Press Release dated October 4, 2004, relating to Apidra®.

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

			AVENTIS
			(Registrant)
Date: October 4, 2004	By:	/s/ Dirk Oldenburg
		Name: Dirk Oldenburg
		Title: General Legal Counsel

Exhibit Index

Exhibit No.		Description
Exhibit 99.1		Press Release dated October 4, 2004, relating to Apidra®.

Filing Compare · AVENTIS